Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium. www.mithra.com 

Biotechnology

Life Sciences

Mithra

Christophe Saillez

Bruno Goulet

Jean-Manuel Fontaine

Stefan Leurs

Cécile Nélissen

Aurélie Deville

Barbara Vrancken

Christophe Maréchal

Operations

Business Development

Leadership Team

Quality Assurance and Compliance Team

Teams at Mithra

Operations

Business Development

Leadership Team

Quality Assurance and Compliance Team